polycythemia vera (pv)

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Completed
  • Polycythemia Vera (PV)
  • Toon-shi, Ehime, Japan
  • +7 more
Dec 8, 2021

Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

Active, not recruiting
  • Polycythemia Vera (PV)
  • Essential Thrombocythemia (ET)
  • Mannheim, Baden-Württemberg, Germany
  • +23 more
Oct 6, 2020

Myeloproliferative Tumors (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Toronto (Upper gastrointestinal

Completed
  • Myeloproliferative Neoplasms (MPN)
  • +3 more
  • Upper gastrointestinal endoscopy and Doppler ultrasound
  • Toronto, Ontario, Canada
  • +1 more
Dec 12, 2019